Semaglutide

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

UT San Antonio study: As FDA approved semaglutide for weight management, calls to poison control centers skyrocketed in the U.S. - EurekAlert!

Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss

Semaglutide linked to lower bone fracture risk - EurekAlert!

Pooled analysis of trails reveals semaglutide shows good efficacy in older adults aged over 65 years - EurekAlert!

Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests

Why Scientists Are Urging Caution About a Common Ingredient in Semaglutide and Ozempic

Doctors Surprised by Semaglutide’s Heart-Saving Effect

Semaglutide and hospitalizations in patients with obesity and established cardiovascular disease - EurekAlert!

GLP-1 medicines semaglutide and tirzepatide reduce the risk of heart failure hospitalization and death by over 40% in patients with heart failure with preserved ejection fraction finds this new study in JAMA

New evidence shows tirzepatide and semaglutide strongly protect the heart

Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide - EurekAlert!

The Lancet: Study confirms cardiovascular benefits of semaglutide beyond weight loss - EurekAlert!

Liraglutide vs semaglutide vs dulaglutide in veterans with type 2 diabetes - EurekAlert!

Nearly 20% Weight Loss Achieved With Higher Dose of Semaglutide, Study Finds

Semaglutide may silence the food noise in your head

Taking semaglutide turns down food noise, research suggests - EurekAlert!

The Lancet Diabetes & Endocrinology: Higher doses of semaglutide can safely enhance weight loss and improve health for adults living with obesity, two new clinical trials confirm - EurekAlert!

Semaglutide reduces cocaine use in rats - EurekAlert!

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction - EurekAlert!